Arrowhead Pharmaceuticals Inc. (ARWR) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Arrowhead Pharmaceuticals...

    NASDAQ: ARWR · Real-Time Price · USD
    36.12
    1.52 (4.39%)
    At close: Oct 03, 2025, 3:59 PM
    36.50
    1.05%
    Pre-market: Oct 06, 2025, 06:19 AM EDT

    Arrowhead Pharmaceuticals Ratios and Metrics

    Financials in USD. Fiscal year is October - September.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
    PE Ratio
    		 -3.87 -14.05 -19.79 -45.98
    PEG Ratio
    		 -0.02 -0.98 -0.87 -0.74
    PS Ratio
    		 653.40 11.98 14.33 46.84
    PB Ratio
    		 12.51 10.63 8.74 15.84
    P/FCF Ratio
    		 -3.84 -8.72 -18.44 43.86
    P/OCF Ratio
    		 -5.01 -18.74 -25.6 37.83
    OCF/S Ratio
    		 -130.34 -0.64 -0.56 1.24
    Debt / Equity Ratio
    		 2.75 1.41 0.20 0.06
    Quick Ratio
    		 6.74 3.98 3.07 2.59
    Current Ratio
    		 6.74 3.98 2.92 2.62
    Asset Turnover
    		 0.00 0.31 0.35 0.19
    Interest Coverage
    		 -18.58 -11.19 n/a n/a
    Return on Equity
    		 -3.23 -0.76 -0.44 -0.34
    Return on Assets
    		 -0.53 -0.27 -0.25 -0.2
    Return on Invested Capital
    		 -0.57 -0.31 -0.31 -0.26
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 1.00 1.00 1.00 1.00
    Net Profit Margin
    		 -168.82 -0.85 -0.72 -1.02
    Pretax Profit Margin
    		 -172.48 -0.86 -0.71 -1.02
    Operating Profit Margin
    		 -169.27 -0.85 -0.73 -1.08
    FCF Margin
    		 -170.18 -1.37 -0.78 1.07
    EBITDA Margin
    		 -158.13 -0.73 -0.67 -0.96

    Add to Watchlist